Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano

Translated title of the contribution: Pharmacoeconomics analysis of prescription in Italian pediatric general practice

R. Campi, L. Garattini, T. Cazzato, D. Capomolla, F. Tediosi, A. Addis, M. Bonati

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Information is lacking regarding the actual cost of drugs used in children. Most drugs used in children are prescribed by general practitioners in an ambulatory setting. In order to evaluate National Health Service (NHS) and family expenditures on drugs used in pediatric general practice, a survey was carried out regarding the ambulatory visits of a group of pediatricians in Southern Italy. Visits were collected throughout a period of 13 weeks (February-April) with an index day methodology and all prescriptions made during the visits were used for the cost analysis. NHS and family costs were evaluated according to reimbursement modalities for drug prescriptions. Total expenditure induced by all prescriptions made during the study period was 148,555,500 Italian lira (ITL); 54% of this was sustained by the NHS, whereas the remaining was paid by families. When costs were corrected according to the actual prescription modalities used by the pediatricians in the survey, including the various reimbursement forms and telephone prescriptions, the result was that 49% of total expenditure was covered by NHS and 51% by families. An analysis of expenditures according to Anatomical Therapeutical Chemical classification system (ATC) showed that drugs for symptomatic therapies (e.g., cough and cold preparations, analgesics, antipyretics, etc.) and vitamins accounted for most of the families' expenditures, whereas antibacterial and antiasthmatic drugs did for the NHS. Of the ten most prescribed drugs, three were charged entirely to the family: acetaminophen (the most prescribed drug), morniflumate, and ambroxol. A large variability in average cost per treated child was found among the different pediatricians, regarding all prescriptions given, antibiotics, for otitis therapy and antibiotics given for otitis. The therapeutic indications that resulted in the major expenditures for families were the common trivial childhood symptoms, such as cough, fever, rhinitis, flu, and pharyngitis. Despite universal coverage for pharmaceutical care, more than half of drug therapy expenditures for children was covered by parents. Prescription attitudes of general practitioners remain the crucial factor for an equal distribution between patients (or parents) and NHS.

Original languageItalian
Pages (from-to)30-35
Number of pages6
JournalGiornale Italiano di Farmacia Clinica
Volume15
Issue number1
Publication statusPublished - 2001

Fingerprint

Pharmaceutical Economics
Health Expenditures
General Practice
National Health Programs
Prescriptions
Pediatrics
Costs and Cost Analysis
Otitis
Cough
Pharmaceutical Preparations
General Practitioners
Parents
Ambroxol
Universal Coverage
Anti-Asthmatic Agents
Anti-Bacterial Agents
Drug Prescriptions
Drug Therapy
Antipyretics
Pharmaceutical Services

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Campi, R., Garattini, L., Cazzato, T., Capomolla, D., Tediosi, F., Addis, A., & Bonati, M. (2001). Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano. Giornale Italiano di Farmacia Clinica, 15(1), 30-35.

Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano. / Campi, R.; Garattini, L.; Cazzato, T.; Capomolla, D.; Tediosi, F.; Addis, A.; Bonati, M.

In: Giornale Italiano di Farmacia Clinica, Vol. 15, No. 1, 2001, p. 30-35.

Research output: Contribution to journalArticle

Campi, R, Garattini, L, Cazzato, T, Capomolla, D, Tediosi, F, Addis, A & Bonati, M 2001, 'Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano', Giornale Italiano di Farmacia Clinica, vol. 15, no. 1, pp. 30-35.
Campi R, Garattini L, Cazzato T, Capomolla D, Tediosi F, Addis A et al. Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano. Giornale Italiano di Farmacia Clinica. 2001;15(1):30-35.
Campi, R. ; Garattini, L. ; Cazzato, T. ; Capomolla, D. ; Tediosi, F. ; Addis, A. ; Bonati, M. / Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano. In: Giornale Italiano di Farmacia Clinica. 2001 ; Vol. 15, No. 1. pp. 30-35.
@article{8967febeb8474d20981b19b94d2188b9,
title = "Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano",
abstract = "Information is lacking regarding the actual cost of drugs used in children. Most drugs used in children are prescribed by general practitioners in an ambulatory setting. In order to evaluate National Health Service (NHS) and family expenditures on drugs used in pediatric general practice, a survey was carried out regarding the ambulatory visits of a group of pediatricians in Southern Italy. Visits were collected throughout a period of 13 weeks (February-April) with an index day methodology and all prescriptions made during the visits were used for the cost analysis. NHS and family costs were evaluated according to reimbursement modalities for drug prescriptions. Total expenditure induced by all prescriptions made during the study period was 148,555,500 Italian lira (ITL); 54{\%} of this was sustained by the NHS, whereas the remaining was paid by families. When costs were corrected according to the actual prescription modalities used by the pediatricians in the survey, including the various reimbursement forms and telephone prescriptions, the result was that 49{\%} of total expenditure was covered by NHS and 51{\%} by families. An analysis of expenditures according to Anatomical Therapeutical Chemical classification system (ATC) showed that drugs for symptomatic therapies (e.g., cough and cold preparations, analgesics, antipyretics, etc.) and vitamins accounted for most of the families' expenditures, whereas antibacterial and antiasthmatic drugs did for the NHS. Of the ten most prescribed drugs, three were charged entirely to the family: acetaminophen (the most prescribed drug), morniflumate, and ambroxol. A large variability in average cost per treated child was found among the different pediatricians, regarding all prescriptions given, antibiotics, for otitis therapy and antibiotics given for otitis. The therapeutic indications that resulted in the major expenditures for families were the common trivial childhood symptoms, such as cough, fever, rhinitis, flu, and pharyngitis. Despite universal coverage for pharmaceutical care, more than half of drug therapy expenditures for children was covered by parents. Prescription attitudes of general practitioners remain the crucial factor for an equal distribution between patients (or parents) and NHS.",
keywords = "Child, Drug utilisazion, General practice, National Health Service, Pediatrics, Pharmacoeconomics",
author = "R. Campi and L. Garattini and T. Cazzato and D. Capomolla and F. Tediosi and A. Addis and M. Bonati",
year = "2001",
language = "Italian",
volume = "15",
pages = "30--35",
journal = "Giornale Italiano di Farmacia Clinica",
issn = "1120-3749",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "1",

}

TY - JOUR

T1 - Analisi farmacoeconomica delle prescrizioni pediatriche extraospedaliere in un contesto italiano

AU - Campi, R.

AU - Garattini, L.

AU - Cazzato, T.

AU - Capomolla, D.

AU - Tediosi, F.

AU - Addis, A.

AU - Bonati, M.

PY - 2001

Y1 - 2001

N2 - Information is lacking regarding the actual cost of drugs used in children. Most drugs used in children are prescribed by general practitioners in an ambulatory setting. In order to evaluate National Health Service (NHS) and family expenditures on drugs used in pediatric general practice, a survey was carried out regarding the ambulatory visits of a group of pediatricians in Southern Italy. Visits were collected throughout a period of 13 weeks (February-April) with an index day methodology and all prescriptions made during the visits were used for the cost analysis. NHS and family costs were evaluated according to reimbursement modalities for drug prescriptions. Total expenditure induced by all prescriptions made during the study period was 148,555,500 Italian lira (ITL); 54% of this was sustained by the NHS, whereas the remaining was paid by families. When costs were corrected according to the actual prescription modalities used by the pediatricians in the survey, including the various reimbursement forms and telephone prescriptions, the result was that 49% of total expenditure was covered by NHS and 51% by families. An analysis of expenditures according to Anatomical Therapeutical Chemical classification system (ATC) showed that drugs for symptomatic therapies (e.g., cough and cold preparations, analgesics, antipyretics, etc.) and vitamins accounted for most of the families' expenditures, whereas antibacterial and antiasthmatic drugs did for the NHS. Of the ten most prescribed drugs, three were charged entirely to the family: acetaminophen (the most prescribed drug), morniflumate, and ambroxol. A large variability in average cost per treated child was found among the different pediatricians, regarding all prescriptions given, antibiotics, for otitis therapy and antibiotics given for otitis. The therapeutic indications that resulted in the major expenditures for families were the common trivial childhood symptoms, such as cough, fever, rhinitis, flu, and pharyngitis. Despite universal coverage for pharmaceutical care, more than half of drug therapy expenditures for children was covered by parents. Prescription attitudes of general practitioners remain the crucial factor for an equal distribution between patients (or parents) and NHS.

AB - Information is lacking regarding the actual cost of drugs used in children. Most drugs used in children are prescribed by general practitioners in an ambulatory setting. In order to evaluate National Health Service (NHS) and family expenditures on drugs used in pediatric general practice, a survey was carried out regarding the ambulatory visits of a group of pediatricians in Southern Italy. Visits were collected throughout a period of 13 weeks (February-April) with an index day methodology and all prescriptions made during the visits were used for the cost analysis. NHS and family costs were evaluated according to reimbursement modalities for drug prescriptions. Total expenditure induced by all prescriptions made during the study period was 148,555,500 Italian lira (ITL); 54% of this was sustained by the NHS, whereas the remaining was paid by families. When costs were corrected according to the actual prescription modalities used by the pediatricians in the survey, including the various reimbursement forms and telephone prescriptions, the result was that 49% of total expenditure was covered by NHS and 51% by families. An analysis of expenditures according to Anatomical Therapeutical Chemical classification system (ATC) showed that drugs for symptomatic therapies (e.g., cough and cold preparations, analgesics, antipyretics, etc.) and vitamins accounted for most of the families' expenditures, whereas antibacterial and antiasthmatic drugs did for the NHS. Of the ten most prescribed drugs, three were charged entirely to the family: acetaminophen (the most prescribed drug), morniflumate, and ambroxol. A large variability in average cost per treated child was found among the different pediatricians, regarding all prescriptions given, antibiotics, for otitis therapy and antibiotics given for otitis. The therapeutic indications that resulted in the major expenditures for families were the common trivial childhood symptoms, such as cough, fever, rhinitis, flu, and pharyngitis. Despite universal coverage for pharmaceutical care, more than half of drug therapy expenditures for children was covered by parents. Prescription attitudes of general practitioners remain the crucial factor for an equal distribution between patients (or parents) and NHS.

KW - Child

KW - Drug utilisazion

KW - General practice

KW - National Health Service

KW - Pediatrics

KW - Pharmacoeconomics

UR - http://www.scopus.com/inward/record.url?scp=0035038523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035038523&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0035038523

VL - 15

SP - 30

EP - 35

JO - Giornale Italiano di Farmacia Clinica

JF - Giornale Italiano di Farmacia Clinica

SN - 1120-3749

IS - 1

ER -